These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23074239)

  • 21. Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia.
    Stanley WC; Morgan EE; Huang H; McElfresh TA; Sterk JP; Okere IC; Chandler MP; Cheng J; Dyck JR; Lopaschuk GD
    Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2304-9. PubMed ID: 16100246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of malonyl coenzyme A decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury.
    Dyck JR; Hopkins TA; Bonnet S; Michelakis ED; Young ME; Watanabe M; Kawase Y; Jishage K; Lopaschuk GD
    Circulation; 2006 Oct; 114(16):1721-8. PubMed ID: 17030679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and structure-activity relationship of small-molecule malonyl coenzyme A decarboxylase inhibitors.
    Cheng JF; Chen M; Wallace D; Tith S; Haramura M; Liu B; Mak CC; Arrhenius T; Reily S; Brown S; Thorn V; Harmon C; Barr R; Dyck JR; Lopaschuk GD; Nadzan AM
    J Med Chem; 2006 Mar; 49(5):1517-25. PubMed ID: 16509570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Palmitate- and lipopolysaccharide-activated macrophages evoke contrasting insulin responses in muscle cells.
    Samokhvalov V; Bilan PJ; Schertzer JD; Antonescu CN; Klip A
    Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E37-46. PubMed ID: 18840759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts.
    Carroll R; Carley AN; Dyck JR; Severson DL
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E900-6. PubMed ID: 15632103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
    Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
    Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice.
    Carvalho-Filho MA; Ueno M; Carvalheira JB; Velloso LA; Saad MJ
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E476-82. PubMed ID: 16638822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.
    Lane MD; Wolfgang M; Cha SH; Dai Y
    Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S49-54. PubMed ID: 18719599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular or pharmacologic perturbation of the link between glucose and lipid metabolism is without effect on glucose-stimulated insulin secretion. A re-evaluation of the long-chain acyl-CoA hypothesis.
    Antinozzi PA; Segall L; Prentki M; McGarry JD; Newgard CB
    J Biol Chem; 1998 Jun; 273(26):16146-54. PubMed ID: 9632669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isofraxidin exhibited anti-inflammatory effects in vivo and inhibited TNF-α production in LPS-induced mouse peritoneal macrophages in vitro via the MAPK pathway.
    Niu X; Xing W; Li W; Fan T; Hu H; Li Y
    Int Immunopharmacol; 2012 Oct; 14(2):164-71. PubMed ID: 22800929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Globular and full-length forms of adiponectin mediate specific changes in glucose and fatty acid uptake and metabolism in cardiomyocytes.
    Palanivel R; Fang X; Park M; Eguchi M; Pallan S; De Girolamo S; Liu Y; Wang Y; Xu A; Sweeney G
    Cardiovasc Res; 2007 Jul; 75(1):148-57. PubMed ID: 17499232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
    Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
    Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urotensin II prevents cardiomyocyte apoptosis induced by doxorubicin via Akt and ERK.
    Chen YL; Loh SH; Chen JJ; Tsai CS
    Eur J Pharmacol; 2012 Apr; 680(1-3):88-94. PubMed ID: 22329895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malonyl-CoA decarboxylase is not a substrate of AMP-activated protein kinase in rat fast-twitch skeletal muscle or an islet cell line.
    Habinowski SA; Hirshman M; Sakamoto K; Kemp BE; Gould SJ; Goodyear LJ; Witters LA
    Arch Biochem Biophys; 2001 Dec; 396(1):71-9. PubMed ID: 11716464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
    Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
    Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
    Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-inflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB, JNK and p38 MAPK inactivation.
    Zhou HY; Shin EM; Guo LY; Youn UJ; Bae K; Kang SS; Zou LB; Kim YS
    Eur J Pharmacol; 2008 May; 586(1-3):340-9. PubMed ID: 18378223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level.
    Lee GY; Kim NH; Zhao ZS; Cha BS; Kim YS
    Biochem J; 2004 Mar; 378(Pt 3):983-90. PubMed ID: 14641110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of a modified human malonyl-CoA decarboxylase blocks the glucose-induced increase in malonyl-CoA level but has no impact on insulin secretion in INS-1-derived (832/13) beta-cells.
    Mulder H; Lu D; Finley J; An J; Cohen J; Antinozzi PA; McGarry JD; Newgard CB
    J Biol Chem; 2001 Mar; 276(9):6479-84. PubMed ID: 11113153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance.
    An J; Muoio DM; Shiota M; Fujimoto Y; Cline GW; Shulman GI; Koves TR; Stevens R; Millington D; Newgard CB
    Nat Med; 2004 Mar; 10(3):268-74. PubMed ID: 14770177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.